Medtech fundings for December 2016

Medtech fundings for December 2016 stand at $905 million, led by the $397 million funding of Microbot Medical as part of its merger with StemCells and followed by the $206 million Series EE funding of Intarcia Therapeutics. Other key fundings include Astute Medical’s $43 million, and Femasys’ $37 million.

Below is a list of the top fundings for the month. For a complete list of fundings for the month, see link.

Source: Compiled by MedMarket Diligence, LLC

For a historical listing of fundings per month since 2009, see link.